Stockreport
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now? [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
the risk of first major adverse cardiovascular events in high-risk primary prevention patients without known significant atherosclerosis and with diabetes when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments. The company's findings were presented in a late-breaking session at the American College of Cardiology (ACC) 75th Annual Scientific Session and also published in the Journal of the American Medical Association. Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate For additional perspective, in its fiscal Q4 and full year 2025 results, Amgen Inc. (NASDAQ:AMGN) reported strong performance in the full year with double-digit growth in revenues and EPS. Total revenues for fiscal Q4 rose 9% to $9.9 billion compared to the prior year period, with product sales growing 7%, driven by 10% volume growth. Total revenues for the full year reached $36.8 billion, up 10% compared to the same quarter last year. Amgen In
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Zai Lab gains after clinical trial pact with Amgen [Seeking Alpha][Seeking Alpha]
- Bristol Myers Squibb adding 3 medications on TrumpRx [FOX Business Network][FOX Business Network]
- Teva gains approval of biosimilar of Amgen's Prolia [Seeking Alpha][Seeking Alpha]
- Amgen (AMGN) Stock Up Since Jim Cramer Said “You Could Do a Lot Worse Than Amgen” [Yahoo! Finance][Yahoo! Finance]
- REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 3/31/26 - Form ARS
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 4
- AMGN's page on the SEC website
- More